SINGLE CELL ANALYSIS OF LENTIVIRAL INTEGRATION TO SUPPORT EX-VIVO GENE MODIFIED CELL THERAPY DEVELOPMENT

被引：0
|
作者：
Di Cerbo, V. [1 ]
Santeramo, I. [1 ]
Hassan, E. [1 ]
Surmacz-Cordle, B. [1 ]
Marshall, D. [1 ]
机构：
[1] Cell & Gene Therapy Catapult, London, England
来源：
CYTOTHERAPY | 2018年 / 20卷 / 05期
关键词：
D O I：
10.1016/j.jcyt.2018.02.035
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
29
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [41] Lentiviral Vector-Mediated Ex Vivo Hematopoietic Stem Cell Gene Therapy for Mucopolysaccharidosis IVA Murine Model
    Celik, Betul
    Rintz, Estera
    Sansanwal, Nidhi
    Khan, Shaukat
    Bigger, Brian
    Tomatsu, Shunji
    HUMAN GENE THERAPY, 2024, 35 (21-22) : 917 - 937
  • [42] JAPANESE REACT TO EX-VIVO GENE-THERAPY PATENT
    NATHAN, R
    NATURE MEDICINE, 1995, 1 (06) : 500 - 500
  • [43] Development of bicistronic lentiviral vectors for continual in vivo and endpoint analysis of gene and stem cell transfer
    Delhove, Juliette M. K. M.
    Waddington, Simon N.
    Ward, Natalie J.
    Jathoul, Amit P.
    Pule, Martin A.
    McKay, Tristan R.
    Buckley, Suzanne M. K.
    HUMAN GENE THERAPY, 2012, 23 (05) : A11 - A12
  • [44] Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency
    Kohn, D. B.
    Booth, C.
    Shaw, K. L.
    Xu-Bayford, J.
    Garabedian, E.
    Trevisan, V.
    Carbonaro-Sarracino, D. A.
    Soni, K.
    Terrazas, D.
    Snell, K.
    Ikeda, A.
    Leon-Rico, D.
    Moore, T. B.
    Buckland, K. F.
    Shah, A. J.
    Gilmour, K. C.
    De Oliveira, S.
    Rivat, C.
    Crooks, G. M.
    Izotova, N.
    Tse, J.
    Adams, S.
    Shupien, S.
    Ricketts, H.
    Davila, A.
    Uzowuru, C.
    Icreverzi, A.
    Barman, P.
    Fernandez, B. Campo
    Hollis, R. P.
    Coronel, M.
    Yu, A.
    Chun, K. M.
    Casas, C. E.
    Zhang, R.
    Arduini, S.
    Lynn, F.
    Kudari, M.
    Spezzi, A.
    Zahn, M.
    Heimke, R.
    Labik, I.
    Parrott, R.
    Buckley, R. H.
    Reeves, L.
    Cornetta, K.
    Sokolic, R.
    Hershfield, M.
    Schmidt, M.
    Candotti, F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (21): : 2002 - 2013
  • [45] Ex Vivo Lentiviral Gene Therapy as a Cure for Murine Pompe Disease
    Stok, Merel
    de Boer, Helen
    Huston, Marshall W.
    Jacobs, Edwin H.
    Roovers, Onno
    Jahr, Holger
    Duncker, Dirk J.
    Visser, Trudi P.
    van der Ploeg, Ans T.
    Reuser, Arnold J. J.
    van Til, Nico P.
    Wagemaker, Gerard
    MOLECULAR THERAPY, 2013, 21 : S105 - S105
  • [46] Ex Vivo and In Vivo Hematopoietic Stem Cell Gene Therapy of Hemophilia A in Mice
    Wang, Hongjie
    Gil, Sucheol
    Doering, Christopher
    Lieber, Andre
    MOLECULAR THERAPY, 2019, 27 (04) : 327 - 327
  • [47] MAPC® cell therapy enhances the ex-vivo expansion of polyclonal, regulatory T cells
    Roobrouck, V.
    Beyens, J.
    Van Houtven, E.
    Reading, J.
    Hull, C.
    Tree, T.
    Lombardi, G.
    Valentin-Torres, A.
    Ting, A.
    CYTOTHERAPY, 2020, 22 (05) : S135 - S136
  • [48] Ex-vivo gene therapy with modified retinal pigment epithelial cells without attachment to microcarriers for parkinsonism
    Subramanian, T
    Venkiteswaran, K
    Redman, P
    Gilbert, E
    MOVEMENT DISORDERS, 2004, 19 : S325 - S325
  • [49] Biochemical Engraftment and Clinical Outcomes Following Ex-Vivo Autologous Stem Cell Gene Therapy for Mucopolysaccharidosis Type IIIA
    Wynn, Robert F.
    Kinsella, Jane L.
    Holley, Rebecca J.
    Potter, Jane
    Thrasher, Adrian J.
    Booth, Claire
    Buckland, Karen
    Izotova, Natalia
    Rust, Stewart
    Weisberg, Daniel
    Church, Heather J.
    Tylee, Karen L.
    Brammeier, Kathryn L.
    Lee, Helena
    Ford, Laura
    Sadegholnejat, Atusa
    Jones, Simon A.
    Ellison, Stuart
    Bigger, Brian
    BLOOD, 2022, 140 : 1897 - 1898
  • [50] The use of ex-vivo stimulation to generate a neoantigen specific T cell product for adoptive T cell therapy
    van Buuren, Marit M.
    van den Berg, Joost H.
    Lenkala, Divya
    Kohler, Jessica
    de Boer, Renate
    Schumacher, Ton N. M.
    Fritsch, Edward F.
    Haanen, John B. A. G.
    Gaynor, Richard B.
    Goldstein, Matthew J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
12345